The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years.

Schichter-Konfino V, Mubariki R, Toubi E, Vadasz Z

Open source

DOI
10.3389/falgy.2024.1464466
Published
2024
Container
Frontiers in allergy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/falgy.2024.1464466,
  title = {The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years.},
  author = {Schichter-Konfino V and Mubariki R and Toubi E and Vadasz Z},
  year = {2024},
  journal = {Frontiers in allergy},
  doi = {10.3389/falgy.2024.1464466},
  url = {https://doi.org/10.3389/falgy.2024.1464466}
}

RIS

TY  - JOUR
TI  - The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years.
AU  - Schichter-Konfino V
AU  - Mubariki R
AU  - Toubi E
AU  - Vadasz Z
PY  - 2024
JO  - Frontiers in allergy
DO  - 10.3389/falgy.2024.1464466
UR  - https://doi.org/10.3389/falgy.2024.1464466
ER  - 

APA

V, S., R, M., E, T., & Z, V. (2024). The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years.. Frontiers in allergy. https://doi.org/10.3389/falgy.2024.1464466

Source records